If this message is not displayed correctly, please click here.

Dear readers,

welcome to our first newletter in 2023.

Lately we celebrated the 5th anniversary of Dynamic42 GmbH! Therefore, we look back on the milestones of the last couple of years, share current highlights and upcoming projects with you.

Click here to go directly to the articles:

Do you have any questions about us and our products or requests for this newsletter?

Please do not hesitate to contact us: info@dynamic42.com 

Enjoy reading and see you soon!
Your Dynamic42 Team
Our academy successfully passes on expertise in organ-on-chip technology

In February, again, scientists took part in our Dynamic42-Academy. Many thanks to all participants for the exciting exchange and the good atmosphere during the academy!

In the intensive course lasting several days with practical learning units and some lectures we taught them how to correctly apply the organ-on-chip technology. The participants learned how to use the systems immediately at a high level in their own research projects, which saves time and considerable costs, e.g. in the field of drug testing.

Press Release

Due to the high demand for the Dynamic42-Academy, the next workshop will already take place from 5th to 7th July 2023. A few places are still available, be quick and secure your participation!

Register Now
5 years of Dynamic42: From milestone to milestone
We celebrated our fifth anniversary this spring. The last few years have been characterised by continuous growth, professionalisation and forward-looking innovations. So, we have quickly grown into a young company established in the biotech sector.

In the last couple of years we have reached several milestones such as setting up our own biochip production, development of organ-on-chip infection models, significant improvement in strategic topics in the area of sales, company growth and team development or future driven cooperations with reasearch groups and several companies.

Now, we are looking forward to another eventful year in which we will be able to announce some great cooperation projects and more of our own developments.

We continue to see far-reaching potential in the idea that animal testing can be reduced or even partly replaced in basic research and pharmaceutical development according to the 3Rs principle (Replace, Reduce, Refine).

The market for organ-on-chip systems, which is becoming increasingly relevant, and with Dynamic42 as part of it, cannot only enable safer testing of pharmaceuticals and substances in the future, but it can also further help to generate new insights into disease processes, therapy options and associated mode of actions as well as approaches to individualised medicine.
Blog: read more
All news at glance: cooperations, projects and more

Collaboration with BAYER, esqLABS and Placenta Lab (UKJ):

We are part of a first-of-its-kind collaboration in the consumer health industry. In cooperation with Bayer AG,   esqLABS GmbH and the Placenta Lab of Jena University Hospital a pilot project was launched, that aims to generate clinically relevant data for evaluating new drug candidates in preclinical research.

The one-year pilot will focus on evaluating whether small molecules can cross the blood-placenta-barrier in pregnant women, an understudied population due to challenges in conducting clinical research.

Funding from the iDEA-iTECH Award:

We are pleased to announce that Dynamic42 is one of the chosen companies and research groups receiving the funding from sanofi. The initiative supports innovators to develop breakthrough technologies that have the potential to improve people’s lives.

Thuringia Sustainability Agreement:

We participate in the Thuringia Sustainability Agreement (NAT). NAT networks sustainable companies, politics, business and administration on topics such as climate and environmental protection, resource conservation, energy efficiency and social sustainability. 

Thank you for your attention and interest. Do you have any questions or suggestions? We welcome your feedback and will be happy to answer your questions. You can also forward this newsletter to interested parties. Information on the protection of your privacy: We guarantee that we will treat the data required for sending, your name and e-mail address, confidentially and will not pass them on or use them for advertising purposes or similar.

You are receiving this mail because you are or were in business contact with Dynamic42 GmbH.
If you no longer wish to receive this email (to: unknown@noemail.com), you can unsubscribe free of charge here.
Your contact details will then be deleted from the distribution list.


Dynamic42 GmbH
Martin Raasch, Knut Rennert
Winzerlaer Straße 2
07745 Jena

03641 508 101